These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 9949676)
21. Use of the READER method of critical appraisal in general practice. Study did not properly answer the questions it posed. van der Wouden JC BMJ; 1998 Sep; 317(7161):819. PubMed ID: 9786688 [No Abstract] [Full Text] [Related]
22. Absence of evidence is not evidence of absence. Alderson P BMJ; 2004 Feb; 328(7438):476-7. PubMed ID: 14988165 [No Abstract] [Full Text] [Related]
23. Strategy for randomised clinical trials in rare cancers. Tan SB; Dear KB; Bruzzi P; Machin D BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959 [TBL] [Abstract][Full Text] [Related]
24. The dangers of subgroup analysis. Stephens R Lancet Oncol; 2001 Jan; 2(1):9. PubMed ID: 11905629 [No Abstract] [Full Text] [Related]
25. Lost sampling units and investigational power. Heaney RP J Bone Miner Res; 1992 Oct; 7(10):1119-21. PubMed ID: 1456081 [No Abstract] [Full Text] [Related]
26. When is a negative study not negative? Scott C; Wasserman T Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):859-61. PubMed ID: 9369135 [TBL] [Abstract][Full Text] [Related]
28. Clinical trials, outcomes, and statistics: how better can be worse. Riggs JE; Hobbs GR Neurology; 1998 Oct; 51(4):1234-5. PubMed ID: 9781583 [No Abstract] [Full Text] [Related]
29. Hypothesis versus significance testing for controlled clinical trials: a dialogue. Salsburg D Stat Med; 1990 Mar; 9(3):201-11; discussion 213-4. PubMed ID: 2343218 [TBL] [Abstract][Full Text] [Related]
30. Statistical testing for baseline differences between randomised groups is not meaningful. Harvey LA Spinal Cord; 2018 Oct; 56(10):919. PubMed ID: 30287888 [No Abstract] [Full Text] [Related]
31. [Analyses of data from randomised trials]. Skovlund E; Lydersen S Tidsskr Nor Laegeforen; 2018 Nov; 138(19):. PubMed ID: 30497239 [No Abstract] [Full Text] [Related]
32. Is the p value really so significant? Verhagen AP; Ostelo RW; Rademaker A Aust J Physiother; 2004; 50(4):261-2. PubMed ID: 15617230 [No Abstract] [Full Text] [Related]
33. Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards. Dehbi HM; Royston P; Hackshaw A BMJ; 2017 May; 357():j2250. PubMed ID: 28546261 [TBL] [Abstract][Full Text] [Related]
34. Reader response: Systematic review and statistical analysis of the integrity of 33 randomized controlled trials. Betensky RA; Chiou SH Neurology; 2018 Mar; 90(12):578. PubMed ID: 29555888 [No Abstract] [Full Text] [Related]
35. [Avoid statistical significance tests within groups in randomized trials]. Skovlund E Tidsskr Nor Laegeforen; 2018 Feb; 138(4):. PubMed ID: 29460565 [No Abstract] [Full Text] [Related]
36. Open access to clinical trials data. Krumholz HM; Peterson ED JAMA; 2014 Sep; 312(10):1002-3. PubMed ID: 25203080 [No Abstract] [Full Text] [Related]
38. How Do We Credit the Evidence Generated From Subgroup Analyses in Randomized Clinical Trials? Cheng Y; He N; Yan Y JAMA Cardiol; 2023 Jun; 8(6):623. PubMed ID: 37074724 [No Abstract] [Full Text] [Related]
39. Re: The Fragility of Statistically Significant Findings from Randomized Controlled Trials in the Urological Literature. Wein AJ J Urol; 2019 Oct; 202(4):666-667. PubMed ID: 31298986 [No Abstract] [Full Text] [Related]
40. How Do We Credit the Evidence Generated From Subgroup Analyses in Randomized Clinical Trials?-Reply. Hlatky MA; Stone NJ; Manson JE JAMA Cardiol; 2023 Jun; 8(6):623. PubMed ID: 37074696 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]